COLL vs LYFT · P/E 17, rev $181.9M vs P/E 108, rev $5.79B
Collegium Pharmaceutical Inc (COLL) versus LYFT Inc (LYFT) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Not investment advice. Open the COLL and LYFT stock pages for the full models.
Not investment advice.